| Cell cycle regulators |
p21 [55] |
Higher stage, recurrence, all-cause mortality |
| p27 [56] |
Higher grade, cancer-specific mortality |
| Ki67 [33] |
Recurrence, progression |
| Cyclin D [55] |
Low grade, low stage, recurrence |
| Cyclin E [55] |
Low stage, recurrence, cancer-specific mortality |
| Apoptosis |
Survivin [32] |
Recurrence, cancer-specific mortality, all-cause mortality |
| Bcl2 [8] |
Recurrence, cancer-specific mortality |
| Caspase-3 [56] |
Recurrence, cancer-specific mortality |
| Angiogenesis |
Micro-vessel density [57] |
Recurrence, all-cause mortality |
| VEGF [58] |
Microvessel density, high grade, recurrence |
| FGFR3 [60] |
Recurrence, cancer-specific mortality |
| Tumor suppressor genes |
p53 [53] |
Higher stage, recurrence, progression, cancer-specific and all-cause mortality |
| pRb [54] |
Higher stage, recurrence, progression, cancer-specific and all-cause mortality |
| Proto-oncogenes & oncogenes |
EGFR [64] |
Higher grade, progression, all-cause mortality |
| Her-2 Neu [64] |
Recurrence, metastasis, cancer-specific mortality |
| FGFR3 [60] |
Low grade, low stage, recurrence and progression |
| Miscellaneous |
GSTT1 [4] |
Recurrence, progression, cancer-specific mortality |
| NOS & PPAR [65] |
Progression, cancer-specific mortality |
| HMOX1 [66] |
Higher grade, recurrence and progression |
